Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Novartis announced its commitment to donate up to 130 million doses of generic hydroxychloroquine to support the global COVID-19 pandemic response.
read more
Wednesday, April 03, 2019
Novartis has entered into an agreement and plan of merger with AveXis to acquire the US-based clinical stage gene therapy company for $218 per share or a total of $8.7 billion in cash.
read more
Novartis is suing Regeneron for patent infringement over the manufacturing process used to produce its Eylea and Zaltrap eye treatments.
read more
Novartis has announced a swap of clinical assets for equity with Mereo BioPharma Group Ltd.
read more
Wednesday, September 02, 2015
Novartis has entered into a global collaboration with Amgen to commercialize and develop pioneering neuroscience treatments.
read more
Novartis is adding to its diverse and deep immuno-oncology pipeline through a strategic alliance and licensing agreement with Surface Oncology. The agreement gives Novartis access to four pre-clinical programs that target regulatory T cell ...
read more
The Novartis Foundation and its partners have begun screening patients in the Community-based Hypertension Improvement Project (ComHIP), a two-year program designed to evaluate the impact of an innovative healthcare model on hypertension management ...
read more
Wednesday, March 07, 2018
Novartis announced an additional strategic alliance with Science 37 to initiate up to 10 new clinical trials over the next three years.
read more
Thursday, December 20, 2018
Novartis has announced an offer to acquire CellforCure from LFB.
read more
Novartis announced Shannon Thyme Klinger, Chief Legal Officer, has decided to resign from Novartis and return to the US to take an executive role at a biotechnology company.
read more
Novartis has announced Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis on March 31, 2019.
read more
Wednesday, October 19, 2022
Bend Bioscience and QHP Capital announced plans to invest in a new operation in Bend, Oregon, an emerging biotechnology R&D and manufacturing epicenter.
read more
Wednesday, December 23, 2020
NovAliX has announced an investment in its DEL platform as part of an eight-year technological cooperation agreement signed with a global pharmaceutical group.
read more
Tuesday, November 30, 2021
NovAliX, a Contract Research Organization (CRO) specializing in drug research and development, announced its partnership with Sanofi for the development of new DNA-Encoded Libraries (DELs). This multi-year agreement will see the partners join forces ...
read more
NovAliX, a drug discovery-focused Contract Research Organization (CRO), today announces the expansion of it's cryogenic electron microscopy (cryo-EM) technology capability.
read more